Pediatrics Neurofeedback with ADHD

From the desk of Dr. Vicki Kelsey,

In November 2012, the American Academy of

Pediatrics approved biofeedback and

Neurofeedback as a Level 1 or "best support"

treatment option for children suffering from ADHD.

Pediatrics. 2014 Mar: 133(3):483-92. doi:10. 1542/peds.2013-2059. Epub 2014 Feb 17

In-school neurofeedback training for ADHD: sustained improvements from a

randomized control trial.:

Steiner NJ 1, Frenette EC, Rene KM, Brennan RT, Perrin EC


OBJECTIVE: To evaluate sustained improvements 6 months after a 40 session, in-school

computer attention training intervention using neurofeedback or cognitive training (CT)

administered to 7-to 11-year-olds with attention-deficit/hyperactivity disorder (ADHD).

METHODS: One hundred four children were randomly assigned to receive neurofeedback, CT,

or a control condition and were evaluated 6 months postintervention. A 3-point growth model

assessed change over time across the conditions on the Conners 3-Parent Assessment Report.

(Conners 3-P), the Behavior Rating Inventory of Executive Function Parent Form (BRIEF), and a

systematic double-blinded classroom observation (Behavioral Observation of Students in

Schools). Analysis of variance assessed community-initiated changes in stimulant medication.

RESULTS: Parent response rates were 90 at the 6-month follow-up. Six months

postintervention, neurofeedback participants maintained significant gains on Conners 3-P

(Inattention effect size [ES] = 0.34. Executive Functioning ES = 0.25. Hyperactivity/Impulsivity

ES = 0.23) and BRIEF subscales including the Global Executive Composite (ES = 0.31), which

remained significantly greater than gains found among children in CT and control conditions.

Children in the CT condition showed delayed improvement over immediate postintervention

ratings only on Conners 3-P Executive Functioning (ES = 0.18) and 2 BRIEF subscales. At the

6-month follow-up, neurofeedback participants maintained the same stimulant medication

dosage, whereas participants in both CT and control conditions showed statistically and

clinically significant increases (9 mg [P = .002] and 13 mg [P < .001], respectively.)

CONCLUSIONS: Neurofeedback participants made more prompt and

greater improvements in ADHD symptoms, which were sustained at the 6-month

follow-up, than did CT participants or those in the control group.

This finding suggests that neurofeedback is a promising attention training

treatment for children with ADHD.